Michaela Ott

Part of MEDITE Cancer Diagnostics, Inc., Medite Enterprise, Inc. develops diagnostics and therapeutic medical devices. The company is based in Orlando, FL. Michael Egbert Ott has been the CEO of the company since 2013. Medite Enterprise was acquired by CytoCore, Inc. on April 04, 2014 for $342 million.

Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a company based in Salzburg, Austria. Medite GmbH develops diagnostics and therapeutic medical devices.

Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a German company that develops diagnostics and therapeutic medical devices. The company is based in Niedersachsen, Germany. The CEO of the company is Elmar A. Dave.

CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL.